Medtronic’s real problem is innovation, not taxation By: MarketWatch June 19, 2014 at 06:45 AM EDT The medical-device company has shifted from engineering to financial engineering, writes Tim Mullaney. Read More >> Related Stocks: Boston Scientific Gilead Sciences Macy's